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Introduction
Reporter genes such as ␤-galactosidase, chloramphenicol acetyltransferase and luciferase have played major roles in understanding the molecular mechanisms of gene expression in cultured cells and in transgenic animals. Reporter genes have also been critically important in designing and characterizing delivery systems for gene transfer into somatic tissues in animals. However, measurement of these reporter genes in living animals requires invasive tissue sampling; either biopsy or death. Green fluorescent protein (GFP) has recently been used for repetitive, non-invasive reporter gene imaging in living cultured cells, single cell organisms and multi-cellular organisms transparent to light. 1, 2 Although in special circumstances GFP and luciferase expression can be measured in vivo in larger animals, 3, 4 these reporter genes cannot generally be used for imaging in living mammals. Reporter gene systems whose expression could be repeatedly and non-invasively examined in all tissues would greatly aid in monitoring both the location and the function of DNA used in gene therapy. Such technology would also provide new approaches to studies of gene expression in transgenic animals.
Positron emission tomography (PET) utilizes positron-labeled molecules to observe and measure biochemical processes in tissues in living individuals. PET probes are typically either positron-labeled ligands for receptors or positron-labeled substrates for intracellular enzymes. Retention of PET probes in tissues generally occurs either as a result of ligand binding to receptor or conversion of substrate to 'trapped' product(s). Retention of the positron-labeled probes can then be imaged, in living subjects, with a PET scanner. 5 We 6,7 and others [8] [9] [10] [11] [12] [13] are developing reporter genes encoding enzymes that convert radioactively labeled substrates to sequestered product(s). Tissue retention of labeled product(s) after systemic substrate administration is a measure of reporter gene expression. If the substrate is labeled with a positron-emitting isotope, PET scans should demonstrate reporter gene-dependent sequestration of the product(s) in vivo. Herpes simplex type 1 virus thymidine kinase (HSV1tk) is currently the most actively investigated enzyme reporter gene for in vivo imaging. HSV1tk-dependent retention of radioactive products has been demonstrated by autoradiography, 6, 8 single photon emission computed tomography (SPECT) 9 and PET. 6, 9 We are developing another reporter gene/reporter probe system for in vivo imaging; the dopamine D 2 receptor (D 2 R) as a reporter gene and its positron-labeled antagonist, 3-(2′-[18F]fluoroethyl)spiperone (FESP), as a reporter probe. FESP can be synthesized at high specific activity, has an IC 50 of 1.5 nm for the D 2 R (compared with 0.94 nm for spiperone), is currently used in humans, and -unlike most HSV1tk substrates -rapidly crosses the blood-brain barrier. [14] [15] [16] The D 2 R is a 415 amino acid protein with seven transmembrane domain topology 17, 18 found in substantial levels primarily in the striatum and pituitary. 19 Because the D 2 R is encoded by an endogenous gene, ectopic expression as a reporter gene should not evoke an immune response. We now report the use of the D 2 R/FESP system repetitively and non-invasively to image reporter gene expression in living mice, using both an adenovirus D 2 R gene delivery system and a D 2 Rexpressing tumor model.
Results
Construction of an adenovirus vector that expresses the dopamine D 2 receptor The rat D 2 R coding sequence 17 was cloned behind the cytomegalovirus (CMV) early promoter and inserted into the E1 region of a replication-deficient type 5 adenovirus to create Ad-D 2 R (Figure 1a ). C6 rat glioma cells were infected with Ad-D 2 R or Ad-␤Gal, a control adenovirus expressing ␤-galactosidase. 20 Total RNA and total cell lysates were prepared 2 days later. Northern analysis demonstrated that Ad-D 2 R infected cells express D 2 R mRNA (not shown). Essentially no receptor-specific [3H]spiperone binding is observed in components in the whole cell homogenates of Ad-␤Gal infected cells. In contrast, substantial [3H]spiperone binding is observed with homogenates of Ad-D 2 R infected cells (Figure 1b) .
Expression of the D 2 R reporter gene in liver, following Ad-D 2 R infection, can be detected with FESP in living mice When mice are injected intravenously with replicationdefective adenovirus vectors expressing heterologous reporter genes, reporter gene expression is overwhelmingly restricted to the liver. 6, 21 Mice were injected by tail vein with 9 × 10 9 plaque forming units (p.f.u.) of either Ad-␤Gal or Ad-D 2 R virus. Two days later the mice were injected via the tail vein with FESP and subsequently imaged by microPET, a PET scanner specifically designed for imaging small animals. 22 Whole body coronal PET images are shown on the left of Figure 2a and b. After the PET scans the mice were killed and frozen, and slices (0.2 mm) were prepared for whole body digital autoradi- PET detection of FESP can repeatedly monitor D 2 R reporter gene expression and pharmacologic D 2 R blockade in Ad-D 2 R infected mice Two nude mice were injected by tail vein with 6 × 10 9 p.f.u. of Ad-D 2 R virus. Two days later, mouse B was injected with (+)butaclamol (2 mg/kg), a D 2 R antagonist, 23 and both mice were then injected with FESP and imaged with microPET. Three days later, (+)butaclamol was administered to mouse A, and both animals were subjected to second FESP injections and microPET imaging. Thus, mouse A was imaged first without antagonist and a second time following antagonist administration, while mouse B was imaged first after antagonist administration and a second time without antagonist. PET images for these four scans are shown in Figure 4 . (+)Butaclamol substantially blocks FESP hepatic retention in the first PET image for mouse B and in the second PET image for mouse A. These studies demonstrate that living animals can be repeatedly assessed for D 2 R reporter gene expression. Antagonist blocking further demonstrates the specificity of the FESP reporter probe for imaging of the D 2 R reporter gene in living animals. D 2 R reporter gene expression can be repeatedly imaged in animals bearing tumors expressing a stable D 2 R transgene In addition to using PET reporter genes to measure expression from somatically transferred DNA, these procedures would be of great use to repeatedly and noninvasively measure reporter gene expression in animals carrying stable transgenes. We used a transplantable tumor expressing the D 2 R to model this application. Parental LTK− cells and LRGB2Zem-1 cells, which express the D 2 R from a 'leaky' metallothionein promoter, 17, 24 were transfected with pMvsrc. 25 Cells able to form tumors in nude mice were selected by animal passage. 
Discussion
Reporter genes have been used to develop many of the currently used somatic gene transfer techniques. However, evaluation of the expression of the reporter genes used to date, eg ␤-galactosidase and luciferase, require that tissue be removed from the experimental animal, either by biopsy or following death. In clinical gene therapy applications it is currently difficult to determine where exogenous genes in modified cell transplants or gene delivery vectors are expressed following transfer into patients, to what extent the transferred DNA is actively expressing its gene product at any given time, or the persistence of expression of the exogenous gene. Both the development of somatic gene transfer technologies in experimental animals and the monitoring of patients 
a) In vivo hepatic [18F] retention (measured by image analysis) as a function of in vitro hepatic FESP retention (measured by well counting). Note that the contribution of hepatic FESP metabolites has been removed from the values determined for FESP retention by well counting, but remain in the image data and contribute to a non-zero intercept. (b) In vivo analysis of hepatic [18F] retention as a function of hepatic D 2 R levels, measured by [3H]spiperone binding. (c) In vivo analysis of hepatic [18F] retention as a function of GAPDH-normalized levels of hepatic D 2 R mRNA, measured by Northern analysis.
undergoing gene therapy would benefit greatly from the ability to determine repetitively and non-invasively where the transferred DNA is being expressed, and to what extent expression occurs over time. We describe here a reporter gene/reporter probe system that can monitor the location, extent and persistence of reporter gene expression in living animals.
In vivo hepatic [18F] retention, determined from PET images, is highly correlated with both in vitro assay of 
u. of Ad-D 2 R virus. Two days later, mouse B was injected intraperitoneally with (+)butaclamol (2 mg/kg). One hour later both mice were injected with FESP. MicroPET scans were performed 3 h after this first FESP administration. Five days after virus injection, mouse A was pretreated with (+)butaclamol. One hour later, both animals were again injected with FESP and scanned a second time in the microPET. Coronal images summed over the whole mouse are shown in units of %ID/g, quantitatively to show image intensity as indicated by the color scale.
hepatic FESP retention by well counting and with increasing D 2 R mRNA levels, the liver appears to saturate in its ability to produce ligand-binding D 2 R receptors. Highly lipophilic FESP diffuses across cell membranes, 14, 15 suggesting that the apparent saturation of ligand-binding D 2 R receptor production is not an artifact of ligand access. It should be emphasized that the characteristics of the FESP PET reporter probe, its metabolism, or the acquisition of PET images and data do not contribute to the lack of correlation of D 2 R mRNA levels and functional D 2 R levels observed at higher levels of D 2 R gene expression. A completely separate measurement of D 2 receptor levels in the livers, [3H]spiperone binding to homogenized liver samples, also demonstrates the inability of the liver to produce functional D 2 receptors at higher D 2 R gene transfer levels. The spiperone binding measure of D 2 R gene expression is independent of the PET reporter probe, the reporter metabolites or the PET scans; it uses a standard ligand binding assay to compare receptor protein expression with receptor message levels.
The D 2 /FESP reporter gene/reporter probe system has the advantage that FESP can be routinely produced by well-characterized procedures. [14] [15] [16] Moreover, alternative positron-emitting ligands such as [11C]raclopride [27] [28] [29] and [11C]N-methylspiperone 30 should also be useful probes for PET detection of the D 2 R reporter gene, and [123I]iodobenzamine 31 should be useful for analyzing the D 2 R reporter gene by SPECT.
Ideally, reporter gene products should not alter cellular metabolism. Ligand-activated D 2 R interacts with G proteins to inhibit adenylate cyclase. 32 Endogenous agonist occupancy of the D 2 R reporter gene product might, therefore, modulate transfected cells. Fortunately, there exist D 2 R mutations that uncouple receptor occupancy from intracellular signaling. [33] [34] [35] We are currently investigating the efficacy of uncoupled D 2 R mutants as reporter genes for in vivo imaging.
Imaging D 2 R expression from a D 2 R reporter gene with FESP should, in principle, be similar to imaging of the endogenous striatal D 2 receptor. [14] [15] [16] However, proper synthesis and membrane insertion of the receptor in other tissues, tissue-specific retention of FESP metabolites in non-D 2 R-dependent fashion, and other variables may modify imaging of the D 2 R reporter gene product. To determine carefully lower levels of detection of this reporter gene in vivo, D 2 R reporter gene expression in inducible models [36] [37] [38] will need to be characterized. It is clear, however, that we can quantitatively determine expression of the D 2 R reporter gene with FESP in vivo, both when the D 2 R is expressed from an infecting viral vector and when the D 2 R is expressed from a stably integrated foreign promoter in heterologous tissue. We anticipate that, by using the D 2 R gene in bicistronic messages, [39] [40] [41] [42] we should be able to determine the location of gene therapy vectors in vivo and repetitively and noninvasively to measure expression of their products. We also anticipate that the D 2 R will be a useful reporter to monitor gene expression repetitively in living transgenic animals.
Materials and methods

Construction and isolation of adenoviruses
The rat cDNA coding the short isoform of the D 2 , cloned in the pGEM-3 EcoRI site, was the gift of David Grandy (Oregon Health Sciences University, Portland, OR, USA). The D 2 R coding region was subcloned into the pACCMVpLpASR(+) EcoRI site, between the cytomegalovirus (CMV) immediate-early promoter and the SV40 splice and poly A sites. 43 This vector was then cotransfected with pJM17 (Microbix Biosystems, Ontario, Canada) into 293 cells to produce Ad-D 2 R, a replicationdeficient type 5 adenovirus expressing D 2 . Ad-D 2 R was plaque purified three times on 293 cells. Ad-␤Gal, an adenovirus expressing ␤-galactosidase, was described previously. 20 High titer adenovirus stocks were prepared in 293 cells. Ad-D 2 R and Ad-␤Gal virus stocks at 3 × 10 10 p.f.u./ml were used for all experiments.
Preparation of RNA and whole cell extracts from C6 cells C6 rat glioma cells (CCL-107, ATCC, Manassas, VA, USA) were grown to 30-50% confluence in 100 mm dishes. Ad-D 2 R or Ad-␤Gal (3 × 10 9 p.f.u.) were added to each dish and incubated for 44 h. RNA was isolated from one set of dishes using the RNeasy Mini Kit (Qiagen, Santa Clarita, CA, USA). Whole cell extracts from a duplicate set of plates were harvested by scraping in 2 ml of TE, 44 repeated freeze-thaw, and sonication. Protein concentrations were determined using the Bio-Rad Protein Assay (Bio-Rad Laboratories, Hercules, CA, USA), with BSA as a standard. 
Dopamine receptor binding assay
Administration of adenovirus to mice
Ten-to 12-week-old male nude mice (NU/NU, 22-31 g, Charles River Labs, Wilmington, MA, USA) were anesthetized by intraperitoneal injection of 50 l of a solution containing (80 mg ketamine and 4 mg xylazine)/ml. Ad-D 2 R or Ad-␤Gal virus in 0.9% NaCl, 30 units heparin sulfate/ml, was injected by tail vein with a 29-gauge insulin syringe (Becton Dickinson, Franklin Lakes, NJ, USA).
Digital whole body autoradiography
Freezing, preparation of sections and autoradiography were performed as described previously, 6 using a FUJI BAS 5000 Phosphorimager and digital plates.
Measurement of FESP retention in liver
After PET scanning, mice were killed and a fraction of the liver (0.3-0.6 g) was rapidly dissected, homogenized in 10 ml of cold Trizol (Life Technologies, Gaithersburg, MD, USA) and frozen at −20°C for subsequent RNA analysis. Another weighed liver fraction (0.3-0.6 g) was ground in 10 ml of homogenizing solution (50 mm TrisHCl 7.5, 6 mm MgCl 2 , 1 mm EDTA, 250 mm sucrose and 300 m PMSF), and a 200 l aliquot of the homogenate was placed in a preweighed 1.8 ml microcentrifuge tube. Diethyl ether (1 ml) was added and the tube was vortexed for 1 min, then centrifuged at 16 000 g for 5 min. After weighing the tube, an aliquot of the upper ether phase was transferred to a second preweighed microcentrifuge tube. After weighing both tubes, radioactivity in both tubes was measured in a Model 1185 Searle well counter (Searle Analytic, Des Plaines, IL, USA). FESP and labeled metabolite retention were calculated from these data, after correction for counting efficiency.
Determination of D 2 R and GAPDH mRNA levels in liver Total RNA was purified from Trizol-liver extracts according to the manufacturer's protocol (Life Technologies). Residual DNA contamination was removed with the RNeasy Mini Kit. RNA concentration was determined spectrophotometrically. Twenty micrograms of each sample was subjected to Northern analysis. 6 Duplicate blots were hybridized with D 2 R or GAPDH 32 P-randomlabeled probes. 6 Luminescence values for D 2 R and GAPDH were measured with the FUJI BAS 5000 Phosphorimager. D 2 R mRNA levels were normalized to GAPDH levels.
microPET and ACAT PET imaging Mice were anesthetized with ketamine/xylazine and injected via the tail vein with FESP (200 Ci; 1000-2000 Ci/mmol) or FDG (200 Ci, 2-5 Ci/mmol). Injected volumes were less than 200 l. Before scanning, mice were again anesthetized and placed in a spread supine position on a cardboard slat. Animals were imaged in the ACAT scanner (CTI PET Systems, Knoxville, TN, USA) and/or the microPET scanner. 22 For ACAT scans, total acquisition time was 10 min. Images were reconstructed using filtered backprojection into a 3-D volume with an isotropic image resolution of approximately 4 mm. Photon attenuation was corrected using a 10 min transmission scan before tracer injection. Acquisition time for whole-body microPET scans was 40 min (5 min per bed position, eight bed positions) and images were reconstructed using 3-D filtered backprojection, with an isotropic image resolution of 1.8 mm. For tumor-bearing animals, images were collected on the ACAT scanner at 1 h after FDG or FESP injection. For all adenovirusinfected animals, images were collected in either the ACAT and/or microPET scanners at 3 h after FESP injection.
Quantification of [18F] retention in murine livers by PET image analysis
Regions of interest (ROI) were drawn over the liver image on decay-corrected whole body coronal images. The counts/pixel/min obtained from the ROI were converted to counts/cc/min using a calibration constant obtained from scanning a cylinder phantom in the PET scanner. The ROI counts/cc/min were converted to counts/g/min, assuming a tissue density of 1 g/cc, and divided by the injected dose to obtain an ROI-derived %ID/g liver. Extensive dissection as well as tissue well counting and image analysis of livers demonstrated that ROI values approximated true tissue counts (not shown).
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